Alice Vrielink - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Biochemistry

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Golden E, Attwood PV, Duff AP, Meilleur F, Vrielink A. Production and characterization of recombinant perdeuterated cholesterol oxidase. Analytical Biochemistry. 485: 102-8. PMID 26073659 DOI: 10.1016/j.ab.2015.06.008  0.44
2014 Piek S, Wang Z, Ganguly J, Lakey AM, Bartley SN, Mowlaboccus S, Anandan A, Stubbs KA, Scanlon MJ, Vrielink A, Azadi P, Carlson RW, Kahler CM. The role of oxidoreductases in determining the function of the neisserial lipid A phosphoethanolamine transferase required for resistance to polymyxin. Plos One. 9: e106513. PMID 25215579 DOI: 10.1371/journal.pone.0106513  0.44
2014 Blythe A, Gunasekara S, Walshe J, Mackay JP, Hartzog GA, Vrielink A. Ubiquitin fusion constructs allow the expression and purification of multi-KOW domain complexes of the Saccharomyces cerevisiae transcription elongation factor Spt4/5. Protein Expression and Purification. 100: 54-60. PMID 24859675 DOI: 10.1016/j.pep.2014.05.005  0.44
2014 Golden E, Karton A, Vrielink A. High-resolution structures of cholesterol oxidase in the reduced state provide insights into redox stabilization Acta Crystallographica Section D: Biological Crystallography. 70: 3155-3166. DOI: 10.1107/S139900471402286X  0.44
2014 Golden EA, Vrielink A. Looking for hydrogen atoms: Neutron crystallography provides novel insights into protein structure and function Australian Journal of Chemistry. 67: 1751-1762. DOI: 10.1071/CH14337  0.44
2013 Wanty C, Anandan A, Piek S, Walshe J, Ganguly J, Carlson RW, Stubbs KA, Kahler CM, Vrielink A. The structure of the neisserial lipooligosaccharide phosphoethanolamine transferase A (LptA) required for resistance to polymyxin. Journal of Molecular Biology. 425: 3389-402. PMID 23810904 DOI: 10.1016/j.jmb.2013.06.029  0.44
2013 Smith NE, Tie WJ, Flematti GR, Stubbs KA, Corry B, Attwood PV, Vrielink A. Mechanism of the dehydrogenase reaction of DmpFG and analysis of inter-subunit channeling efficiency and thermodynamic parameters in the overall reaction. The International Journal of Biochemistry & Cell Biology. 45: 1878-85. PMID 23742989 DOI: 10.1016/j.biocel.2013.05.028  0.44
2013 Golden E, Paterson R, Tie WJ, Anandan A, Flematti G, Molla G, Rosini E, Pollegioni L, Vrielink A. Structure of a class III engineered cephalosporin acylase: comparisons with class I acylase and implications for differences in substrate specificity and catalytic activity. The Biochemical Journal. 451: 217-26. PMID 23373797 DOI: 10.1042/BJ20121715  0.44
2010 Gunasekara S, Vrielink A, Stubbs KA. Preliminary studies into the inhibition of the cholesterol alpha-glucosyltransferase from Helicobacter pylori using azasugars. Carbohydrate Research. 345: 960-4. PMID 20307874 DOI: 10.1016/j.carres.2010.03.003  0.44
2009 Lyubimov AY, Chen L, Sampson NS, Vrielink A. A hydrogen-bonding network is important for oxidation and isomerization in the reaction catalyzed by cholesterol oxidase. Acta Crystallographica. Section D, Biological Crystallography. 65: 1222-31. PMID 19923719 DOI: 10.1107/S0907444909037421  0.44
2008 Chen L, Lyubimov AY, Brammer L, Vrielink A, Sampson NS. The binding and release of oxygen and hydrogen peroxide are directed by a hydrophobic tunnel in cholesterol oxidase. Biochemistry. 47: 5368-77. PMID 18410129 DOI: 10.1021/bi800228w  0.44
2007 Lyubimov AY, Heard K, Tang H, Sampson NS, Vrielink A. Distortion of flavin geometry is linked to ligand binding in cholesterol oxidase. Protein Science : a Publication of the Protein Society. 16: 2647-56. PMID 18029419 DOI: 10.1110/ps.073168207  0.44
2006 Lim L, Molla G, Guinn N, Ghisla S, Pollegioni L, Vrielink A. Structural and kinetic analyses of the H121A mutant of cholesterol oxidase. The Biochemical Journal. 400: 13-22. PMID 16856877 DOI: 10.1042/BJ20060664  0.44
2006 Lyubimov AY, Lario PI, Moustafa I, Vrielink A. Atomic resolution crystallography reveals how changes in pH shape the protein microenvironment. Nature Chemical Biology. 2: 259-64. PMID 16604066 DOI: 10.1038/nchembio784  0.88
2003 Vrielink A, Sampson N. Sub-Ångstrom resolution enzyme X-ray structures: Is seeing believing? Current Opinion in Structural Biology. 13: 709-715. PMID 14675549 DOI: 10.1016/j.sbi.2003.10.012  0.44
2003 Lario PI, Vrielink A. Atomic resolution density maps reveal secondary structure dependent differences in electronic distribution. Journal of the American Chemical Society. 125: 12787-94. PMID 14558826 DOI: 10.1021/ja0289954  0.88
2003 Sampson NS, Vrielink A. Cholesterol oxidases: a study of nature's approach to protein design. Accounts of Chemical Research. 36: 713-22. PMID 12974654 DOI: 10.1021/ar9800587  0.44
2003 Lario PI, Sampson N, Vrielink A. Sub-atomic resolution crystal structure of cholesterol oxidase: What atomic resolution crystallography reveals about enzyme mechanism and the role of the FAD cofactor in redox activity Journal of Molecular Biology. 326: 1635-1650. PMID 12595270 DOI: 10.1016/S0022-2836(03)00054-8  0.44
2002 Gao YS, Vrielink A, MacKenzie R, Sztul E. A novel type of regulation of the vimentin intermediate filament cytoskeleton by a Golgi protein. European Journal of Cell Biology. 81: 391-401. PMID 12160147 DOI: 10.1078/0171-9335-00260  0.44
2002 Burns CS, Aronoff-Spencer E, Dunham CM, Lario P, Avdievich NI, Antholine WE, Olmstead MM, Vrielink A, Gerfen GJ, Peisach J, Scott WG, Millhauser GL. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry. 41: 3991-4001. PMID 11900542 DOI: 10.1021/bi011922x  0.44
2001 Yin Y, Sampson NS, Vrielink A, Lario PI. The presence of a hydrogen bond between asparagine 485 and the pi system of FAD modulates the redox potential in the reaction catalyzed by cholesterol oxidase. Biochemistry. 40: 13779-87. PMID 11705367 DOI: 10.1021/bi010843i  0.44
2001 Lario PI, Bobechko B, Bateman K, Kelly J, Vrielink A, Huang Z. Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells. Archives of Biochemistry and Biophysics. 394: 54-60. PMID 11566027 DOI: 10.1006/abbi.2001.2513  0.88
2001 Zhang L, Ahvazi B, Szittner R, Vrielink A, Meighen E. Differences in nucleotide specificity and catalytic mechanism between Vibrio harveyi aldehyde dehydrogenase and other members of the aldehyde dehydrogenase superfamily Chemico-Biological Interactions. 130: 29-38. PMID 11306028 DOI: 10.1016/S0009-2797(00)00219-2  0.44
2000 Zhang L, Ahvazi B, Szittner R, Vrielink A, Meighen E. A histidine residue in the catalytic mechanism distinguishes Vibrio harveyi aldehyde dehydrogenase from other members of the aldehyde dehydrogenase superfamily Biochemistry. 39: 14409-14418. PMID 11087393 DOI: 10.1021/bi0014913  0.44
2000 Ahvazi B, Coulombe R, Delarge M, Vedadi M, Zhang L, Meighen E, Vrielink A. Crystal structure of the NADP+-dependent aldehyde dehydrogenase from Vibrio harveyi: Structural implications for cofactor specificity and affinity Biochemical Journal. 349: 853-861. PMID 10903148  0.44
2000 Kohls D, Sulea T, Purisima EO, MacKenzie RE, Vrielink A. The crystal structure of the formiminotransferase domain of formiminotransferase-cyclodeaminase: Implications for substrate channeling in a bifunctional enzyme Structure. 8: 35-46. PMID 10673422 DOI: 10.1016/S0969-2126(00)00078-2  0.44
1999 Zhang L, Ahvazi B, Szittner R, Vrielink A, Meighen E. Change of nucleotide specificity and enhancement of catalytic efficiency in single point mutants of Vibrio harveyi aldehyde dehydrogenase Biochemistry. 38: 11440-11447. PMID 10471295 DOI: 10.1021/bi991101g  0.44
1999 Kohls D, Croteau N, Mejia N, MacKenzie RE, Vrielink A. Crystallization and preliminary X-ray analysis of the formiminotransferase domain from the bifunctional enzyme formiminotransferase-cyclodeaminase Acta Crystallographica Section D: Biological Crystallography. 55: 1206-1208. PMID 10329787 DOI: 10.1107/S0907444999003601  0.44
1999 Yue QK, Kass IJ, Sampson NS, Vrielink A. Crystal structure determination of cholesterol oxidase from Streptomyces and structural characterization of key active site mutants. Biochemistry. 38: 4277-86. PMID 10194345 DOI: 10.1021/bi982497j  0.44
1997 Vedadi M, Vrielink A, Meighen E. Involvement of conserved glycine residues, 229 and 234, of Vibrio harveyi aldehyde dehydrogenase in activity and nucleotide binding Biochemical and Biophysical Research Communications. 238: 448-451. PMID 9299529 DOI: 10.1006/bbrc.1997.7300  0.44
1997 Vedadi M, Croteau N, Delarge M, Vrielink A, Meighen E. Structural and functional studies of a NADP+-specific aldehyde dehydrogenase from the luminescent marine bacterium Vibrio harveyi Advances in Experimental Medicine and Biology. 414: 269-275. PMID 9059630  0.44
1996 Croteau N, Vedadi M, Delarge M, Meighen E, Abu-Abed M, Howell PL, Vrielink A. Crystallization and preliminary X-ray analysis of aldehyde dehydrogenase from Vibrio harveyi. Protein Science : a Publication of the Protein Society. 5: 2130-2. PMID 8897616 DOI: 10.1002/pro.5560051022  0.44
1991 Vrielink A, Lloyd LF, Blow DM. Crystal structure of cholesterol oxidase from Brevibacterium sterolicum refined at 1.8 A resolution. Journal of Molecular Biology. 219: 533-54. PMID 2051487 DOI: 10.1016/0022-2836(91)90192-9  0.44
Show low-probability matches.